[HTML][HTML] Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
C Elfgen, C Leo, RA Kubik-Huch, S Muenst, N Schmidt… - Virchows Archiv, 2023 - Springer
The heterogeneous group of B3 lesions in the breast harbors lesions with different
malignant potential and progression risk. As several studies about B3 lesions have been …
malignant potential and progression risk. As several studies about B3 lesions have been …
[HTML][HTML] Should low-risk DCIS lose the cancer label? An evidence review
Background Population mammographic screening for breast cancer has led to large
increases in the diagnosis and treatment of ductal carcinoma in situ (DCIS). Active …
increases in the diagnosis and treatment of ductal carcinoma in situ (DCIS). Active …
The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): A …
C Cullinane, J Byrne, L Kelly, MO Sullivan… - European Journal of …, 2022 - Elsevier
Introduction High-risk or B3 breast lesions are considered lesions of uncertain malignant
potential and comprise between 5 and 12% of initial biopsy results. We sought to perform a …
potential and comprise between 5 and 12% of initial biopsy results. We sought to perform a …
Management and risk of upgrade of atypical ductal hyperplasia in the breast: A population-based retrospective cohort study
C Wadsten, G Rask - Scandinavian Journal of Surgery, 2024 - journals.sagepub.com
Background: International guidelines recommend open surgery for atypical ductal
hyperplasia (ADH) in the breast due to risk of underestimating malignant disease …
hyperplasia (ADH) in the breast due to risk of underestimating malignant disease …
[HTML][HTML] A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with low-grade ductal carcinoma in situ of the breast
L Nicosia, AC Bozzini, S Penco, C Trentin… - Cancers, 2022 - mdpi.com
Simple Summary Surgical management is currently the main standard of care procedure
used in order to treat ductal carcinoma in situ (DCIS) of the breast. Nevertheless, the survival …
used in order to treat ductal carcinoma in situ (DCIS) of the breast. Nevertheless, the survival …
B3 lesions of the breast: histological, clinical, and epidemiological aspects: update
Z Varga, P Sinn, A Lebeau - Pathologie (Heidelberg, Germany), 2023 - europepmc.org
B3-Läsionen der Mamma stellen eine heterogene Gruppe von Läsionen mit unsicherem
Malignitätspotenzial dar, welche histologisch klar definierte Diagnosen beinhalten und …
Malignitätspotenzial dar, welche histologisch klar definierte Diagnosen beinhalten und …
[HTML][HTML] Atypical Ductal Hyperplasia and Lobular In Situ Neoplasm: High-Risk Lesions Challenging Breast Cancer Prevention
L Nicosia, L Mariano, G Pellegrino, F Ferrari… - Cancers, 2024 - mdpi.com
Simple Summary This retrospective study investigates histopathological outcomes, upgrade
rates, and disease-free survival (DFS) in high-risk breast lesions, including atypical ductal …
rates, and disease-free survival (DFS) in high-risk breast lesions, including atypical ductal …
[HTML][HTML] Atypical ductal hyperplasia on vacuum-assisted breast biopsy: a scoring system to predict the risk of upgrade to malignancy
R Rella, M Conti, A Borghetti, P Belli, F Morciano… - La radiologia …, 2024 - Springer
Rationale and objectives Our multicentric study analysed clinical, radiologic and pathologic
features in patients with atypical ductal hyperplasia (ADH) diagnosed with vacuum-assisted …
features in patients with atypical ductal hyperplasia (ADH) diagnosed with vacuum-assisted …
[PDF][PDF] Long-term follow-up of high-risk breast lesions at vacuum-assisted biopsy without subsequent surgical resection
C Elfgen, Z Varga, K Breitling, E Pauli… - Breast Care, 2024 - karger.com
Introduction: B3-lesions of the breast are a heterogeneous group of neoplasms, associated
with a higher risk of breast cancer. Recent studies show a low upgrade rate into malignancy …
with a higher risk of breast cancer. Recent studies show a low upgrade rate into malignancy …
Active Surveillance for Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ
R Miceli, CL Mercado, O Hernandez… - Journal of Breast …, 2023 - academic.oup.com
Atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS) are relatively
common breast lesions on the same spectrum of disease. Atypical ductal hyperblasia is a …
common breast lesions on the same spectrum of disease. Atypical ductal hyperblasia is a …